Anne-Marie Connolly-Andersen1, Heather Whitaker2, Jonas Klingström3, Clas Ahlm1. 1. Unit of Infectious Diseases, Department of Clinical Microbiology, Umeå University, Sweden. 2. Department of Mathematics and Statistics, Open University, Milton Keynes, United Kingdom. 3. Centre for Infectious Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Abstract
Background: Bleeding is associated with viral hemorrhagic fevers; however, thromboembolic complications have received less attention. Hemorrhagic fever with renal syndrome (HFRS) is a mild viral hemorrhagic fever caused by Puumala hantavirus. We previously identified HFRS as a risk factor for myocardial infarction and stroke, but the risk for venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is unknown. Methods: Personal identity numbers from the Swedish HFRS database were cross-linked with the National Patient register to obtain information on all causes for hospitalization during 1964 to 2013. The self-controlled case series method was used to calculate the incidence rate ratio (IRR) for first VTE, DVT, and PE during 1998 to 2013. Results: From 7244 HFRS patients, there were 146 with a first VTE of which 74 were DVT and 78 were PE, and 6 patients had both DVT and PE. The overall risk for a VTE was significantly higher during the first 2 weeks following HFRS onset, with an IRR of 64.3 (95% confidence interval [CI], 36.3-114). The corresponding risk for a DVT was 45.9 (95% CI, 18-117.1) and for PE, 76.8 (95% CI, 37.1-159). Sex interacted significantly with the association between HFRS and VTE, with females having a higher risk compared with males. Conclusions: A significantly increased risk for VTE was found in the time period following HFRS onset. It is important to keep this in mind and monitor HFRS patients, and possibly other viral hemorrhagic fever patients, for early symptoms of VTE.
Background: Bleeding is associated with viral hemorrhagic fevers; however, thromboembolic complications have received less attention. Hemorrhagic fever with renal syndrome (HFRS) is a mild viral hemorrhagic fever caused by Puumala hantavirus. We previously identified HFRS as a risk factor for myocardial infarction and stroke, but the risk for venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is unknown. Methods: Personal identity numbers from the Swedish HFRS database were cross-linked with the National Patient register to obtain information on all causes for hospitalization during 1964 to 2013. The self-controlled case series method was used to calculate the incidence rate ratio (IRR) for first VTE, DVT, and PE during 1998 to 2013. Results: From 7244 HFRSpatients, there were 146 with a first VTE of which 74 were DVT and 78 were PE, and 6 patients had both DVT and PE. The overall risk for a VTE was significantly higher during the first 2 weeks following HFRS onset, with an IRR of 64.3 (95% confidence interval [CI], 36.3-114). The corresponding risk for a DVT was 45.9 (95% CI, 18-117.1) and for PE, 76.8 (95% CI, 37.1-159). Sex interacted significantly with the association between HFRS and VTE, with females having a higher risk compared with males. Conclusions: A significantly increased risk for VTE was found in the time period following HFRS onset. It is important to keep this in mind and monitor HFRSpatients, and possibly other viral hemorrhagic feverpatients, for early symptoms of VTE.
Authors: Felix C Koehler; Veronica Di Cristanziano; Martin R Späth; K Johanna R Hoyer-Allo; Manuel Wanken; Roman-Ulrich Müller; Volker Burst Journal: Clin Kidney J Date: 2022-01-29
Authors: Clare M Schmedes; Steven P Grover; Yohei M Hisada; Marco Goeijenbier; Johan Hultdin; Sofie Nilsson; Therese Thunberg; Clas Ahlm; Nigel Mackman; Anne-Marie Fors Connolly Journal: J Infect Dis Date: 2020-09-14 Impact factor: 5.226
Authors: Sirpa Koskela; Satu Mäkelä; Tomas Strandin; Antti Vaheri; Tuula Outinen; Lotta Joutsi-Korhonen; Ilkka Pörsti; Jukka Mustonen; Outi Laine Journal: Viruses Date: 2021-08-06 Impact factor: 5.048
Authors: J Klingström; A Smed-Sörensen; K T Maleki; C Solà-Riera; C Ahlm; N K Björkström; H G Ljunggren Journal: J Intern Med Date: 2019-02-17 Impact factor: 8.989
Authors: Marlene Tarvainen; Satu Mäkelä; Outi Laine; Ilkka Pörsti; Sari Risku; Onni Niemelä; Jukka Mustonen; Pia Jaatinen Journal: Viruses Date: 2021-09-13 Impact factor: 5.048